ANNUAL REPORT

Company

TENAX THERAPEUTICS, INC.

Filed

July 29, 2014

Period of Report

April 30, 2014

Accession Number

0001354488-14-003782

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →